Under Siege: The Brain on Opiates

Slides:



Advertisements
Similar presentations
1 Chapter 14 Catecholamines Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Advertisements

Office-Based Opioid Therapy: Methadone/Buprenorphine Nexus
The Addicted Synapse Katie Malanson.
Opiate and Nicotine Addiction: Involvement of cAMP Response Element Binding Protein (CREB) Matt Wolfe
Topics for this lecture Drugs - All drugs of abuse induce dopamine release (?) The anatomy of the reward pathway defines the road to drug abuse (?) Cellular.
組員 :Sam Wang 王煜豪 Pony Lien 連顥庭.  Reward-- positive value of an internal physical state  Incentive motivation Affect (Want) (Like)  Incentive salience.
Y. Wang†,‡, A. Ghezzi†, J. C. P. Yin§,¶ and N. S. Atkinson
Neuro Unit 5: How do our choices change our brains?
Neurological Disorders Lesson 5.2 How do drugs alter synaptic transmission? Human Brain Rat Brain.
Physiology and Behaviour of Withdrawal Syndrome Idrees M, Hussain A, Hyman A, Humphries R & Hughes E. Introduction On administering certain drugs for long.
Increased Energy “It sustains and refreshes both body and brain in the same space of time more than double the amount of work could be undergone...”
The Reward Pathway And Addiction
Turn in Problem set 4 Friday UNIT FIVE. Review: What is a monoamine? 1.A metabolic enzyme 2.A molecule with a CH 3 group on it 3.A molecule with an NH.
Assessment Statements Obj. E4.1 1 E4.2 3 E4.3 E4.4
Upregulation of the cAMP pathway as a mechanism of opiate tolerance and dependence. Opiates acutely inhibit the functional activity of the cAMP pathway.
Drugs and The Nervous System
Pharmacology ii Tutoring
P.W. Kalivas, N. Volkow, J. Seamans  Neuron 
How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission
The Role of Gβγ in Opioid Tolerance and Withdrawal
Narcotic drugs introduction
A Constraint on cAMP Signaling
Neuronal Differentiation
A Death Trap for Microglia
Christa Buecker, Niels Geijsen  Cell Stem Cell 
Shining light on vitamin D trials in chronic kidney disease
Current View: Intestinal Stem Cells and Signaling
Multiple Actions of Spinophilin Regulate Mu Opioid Receptor Function
Neuroscience of Addiction
Volume 82, Issue 6, Pages (June 2014)
Volume 71, Issue 4, Pages (August 2011)
Drug Abuse Munir Gharaibeh, MD, PhD, MHPE
Audrey C. Brumback, MD, PhD  Pediatric Neurology 
Endocannabinoid Signaling and Synaptic Function
Hedgehog Signaling: Is Smo a G Protein-Coupled Receptor?
Shedding “UV” Light on Endogenous Opioid Dependence
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Andrew K Finn, Jennifer L Whistler  Neuron 
Martin G. Myers, Heike Münzberg, Gina M. Leinninger, Rebecca L. Leshan 
Group 1 mGluR-Dependent Synaptic Long-Term Depression: Mechanisms and Implications for Circuitry and Disease  Christian Lüscher, Kimberly M. Huber  Neuron 
Neurobiology of Depression
Memory Takes Time Neuron Volume 95, Issue 2, Pages (July 2017)
Volume 62, Issue 3, Pages (May 2009)
Enlightening the adrenal gland
Volume 6, Issue 8, Pages (August 1996)
Amines, Astrocytes, and Arousal
Internet Sex Addiction Treated With Naltrexone
Current Compensation in Neuronal Homeostasis
Volume 45, Issue 3, Pages (February 2005)
Volume 26, Issue 1, Pages (April 2000)
Intracellular Ca2+ Release and Ischemic Axon Injury
Age-Related Memory Impairment
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Courting a Cure for Fragile X
David A. Lewis, Allison A. Curley, Jill R. Glausier, David W. Volk 
Marco Pignatelli, Antonello Bonci  Neuron 
Volume 93, Issue 6, Pages (June 1998)
Volume 22, Issue 17, Pages R705-R711 (September 2012)
Volume 60, Issue 2, Pages (August 2001)
G proteins and hypertension: An alternative candidate gene approach
Aya Matsui, Veronica A. Alvarez  Neuron 
Mushroom Bodies, Ca2+ Oscillations, and the Memory Gene amnesiac
Eric N. Johnson, PhD, Kirk M. Druey, MD 
Neuronal Calcium Signaling
The Dopamine D2 Receptor: New Surprises from an Old Friend
Tibor Harkany, Tamas L. Horvath  Cell Metabolism 
Memory Mechanisms: A common cascade for long-term memory
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Zuzana Tothova, D. Gary Gilliland  Cell Stem Cell 
Volume 20, Issue 1, Pages R31-R36 (January 2010)
Presentation transcript:

Under Siege: The Brain on Opiates Eric J Nestler  Neuron  Volume 16, Issue 5, Pages 897-900 (May 1996) DOI: 10.1016/S0896-6273(00)80110-5

Figure 1 Scheme Illustrating Opiate Actions in the LC Opiates acutely inhibit LC neurons by increasing the conductance of a K+ channel (light cross-hatch) via coupling with subtypes of Gi and/or Go and by decreasing a Na+-dependent inward current (dark cross-hatch) via coupling with Gi/o and the consequent inhibition of adenylyl cyclase. Reduced levels of cAMP decrease PKA activity and the phosphorylation of the responsible channel or pump. Inhibition of the cAMP pathway also decreases phosphorylation of numerous other proteins and thereby affects many additional processes in the neuron. For example, it reduces the phosphorylation state of CREB, which may initiate some of the longer-term changes in LC function. Upward bold arrows summarize the effects of chronic morphine in the LC. Chronic morphine increases levels of adenylyl cyclase, PKA, and several phosphoproteins, including CREB. These changes contribute to the altered phenotype of the drug-addicted state. For example, the intrinsic excitability of LC neurons is increased via enhanced activity of the cAMP pathway and Na+-dependent inward current, which contributes to the tolerance, dependence, and withdrawal exhibited by these neurons. This altered phenotypic state may be maintained in part by up-regulation of CREB expression. Neuron 1996 16, 897-900DOI: (10.1016/S0896-6273(00)80110-5)

Figure 2 Scheme Illustrating Changes in Mesolimbic Dopamine Function Associated with Opiate Addiction (A) VTA neuron projecting to an NAc neuron under normal conditions. (B) The same neurons after chronic opiate exposure. Acutely, opiates produce potent effects both in the VTA and in the NAc. After chronic exposure, opiates produce long-term adaptations in both regions, which oppose these acute effects. In the VTA, there is a gross reduction in the size and, presumably, functioning of these neurons, which would oppose their activation by acute opiate exposure. In the NAc, there is an up-regulation of the cAMP pathway, which would oppose acute opiate inhibition of this pathway. Upon removal of the opiate, these adaptations would lead to impairment in mesolimbic dopamine function, which could contribute to an aversive state during withdrawal. Neuron 1996 16, 897-900DOI: (10.1016/S0896-6273(00)80110-5)